Grundinformationen
- Standard-SMILES
CC(C)(C)OC(=O)NCC(=O)O- InChIKey
VRPJIFMKZZEXLR-UHFFFAOYSA-N- Summenformel
- C7H13NO4
- Durchschnittliche Molmasse
- 175,18 g/mol
- Monoisotopische Masse
- 175,0844579
Namen und Bezeichner
- Bevorzugter Name
- N-(tert-butoxycarbonyl)glycine
- IUPAC
- 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid
- Lokaler Name
- N-(tert-Butoxycarbonyl)glycin
- Englischer Name
- BOC-Glycine
- Summenformel
- C7H13NO4
- Molmasse
- 175.18
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
4530-20-5- PubChem CID
- 78288
- DTXSID
DTXSID2063509- ChEMBL
CHEMBL508605- EC Number
- 224-864-5
- Nikkaji
- J57.777D
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 0,5
- Polarare Oberfläche (TPSA)
- 75,6 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 12
- Formalladung
- 0
- Komplexität
- 182
Physikochemische Eigenschaften
- Schmelzpunkt
- 86 · 86-89 °C(lit.)
- Siedepunkt
- 306.47 °C · 306.47°C (rough estimate)
- Dichte
- 1.2843 · 1.2843 (rough estimate)
- Brechungsindex
- 1.4353 · 1.4353 (estimate)
- storage temp.
- Keep in dark place,Sealed in dry,Room Temperature
- Löslichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Powder
- pka
- 4 · 4.00±0.10(Predicted)
- Farbe
- White to off-white
- Wasserlöslichkeit
- soluble
- BRN
- 1101514 · 1101514
- Major Application
- peptide synthesis
- InChI
- InChI=1S/C7H13NO4/c1-7(2,3)12-6(11)8-4-5(9)10/h4H2,1-3H3,(H,8,11)(H,9,10)
- InChIKey
- VRPJIFMKZZEXLR-UHFFFAOYSA-N
- SMILES
- C(O)(=O)CNC(OC(C)(C)C)=O
- CAS Datenbank
- 4530 · 4530-20-5(CAS DataBase Reference)
- EPA chemische Informationen
- Glycine, N-[(1,1-dimethylethoxy)carbonyl]- (4530-20-5)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
This chemical does not meet GHS hazard criteria for 38.4% (38 of 99) of reports.
Danger
H302 (53.5%): Harmful if swallowed [Warning Acute toxicity, oral];H318 (61.6%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P264, P264+P265, P270, P280, P301+P317, P305+P354+P338, P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 99 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 38 of 99 reports by companies.;There are 4 notifications provided by 61 of 99 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Regulatorische Informationen
Sicherheitsdaten
- wgk
- 3
- tsca
- TSCA listed
- ridadr
- UN2811
- hs_code
- 29241990
- risk_code
- 22-41-36/37/38-20/21/22
- hazard_code
- Xn,Xi
- safety_code
- 26-36/37/39-39-36
- hazard_class
- 6.1
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Verwendung und Herstellung
Anwendungen
VerwendenBOC-Glycine is used in the composition of drugs containing Ketoprofen, and Sodium hyaluronate as antiinflammatory agents.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…